Alnylam Pharmaceuticals
ALNY
#458
Rank
A$77.13 B
Marketcap
A$583.83
Share price
-5.88%
Change (1 day)
46.65%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company